GLP-1 drugs have shifted from medical to mainstream, and the impact is rippling far beyond health. From luxury to lifestyle, brands must now rewrite advertising and marketing playbooks for consumers who crave control over indulgence. Industry leaders at Havas and Publicis Luxe weigh in on what’s at stake, and what’s next.Read More
The rise of a lifestyle drug: GLP-1s will force more than just food brands to pivot
By Amy Houston
